SG11202112449SA - Functional recovery from cerebral infarction - Google Patents

Functional recovery from cerebral infarction

Info

Publication number
SG11202112449SA
SG11202112449SA SG11202112449SA SG11202112449SA SG11202112449SA SG 11202112449S A SG11202112449S A SG 11202112449SA SG 11202112449S A SG11202112449S A SG 11202112449SA SG 11202112449S A SG11202112449S A SG 11202112449SA SG 11202112449S A SG11202112449S A SG 11202112449SA
Authority
SG
Singapore
Prior art keywords
cerebral infarction
functional recovery
recovery
functional
infarction
Prior art date
Application number
SG11202112449SA
Inventor
Silviu Itescu
Original Assignee
Mesoblast Int Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2019901756A external-priority patent/AU2019901756A0/en
Application filed by Mesoblast Int Sarl filed Critical Mesoblast Int Sarl
Publication of SG11202112449SA publication Critical patent/SG11202112449SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
SG11202112449SA 2019-05-23 2020-05-22 Functional recovery from cerebral infarction SG11202112449SA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2019901756A AU2019901756A0 (en) 2019-05-23 Functional recovery from Cerebral Infarction
AU2019902024A AU2019902024A0 (en) 2019-06-11 Functional recovery from Cerebral Infarction
PCT/EP2020/064271 WO2020234450A1 (en) 2019-05-23 2020-05-22 Functional recovery from cerebral infarction

Publications (1)

Publication Number Publication Date
SG11202112449SA true SG11202112449SA (en) 2021-12-30

Family

ID=70922001

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202112449SA SG11202112449SA (en) 2019-05-23 2020-05-22 Functional recovery from cerebral infarction

Country Status (9)

Country Link
US (1) US20220226386A1 (en)
EP (1) EP3972615A1 (en)
JP (1) JP2022533781A (en)
KR (1) KR20220011621A (en)
CN (1) CN113853206A (en)
AU (1) AU2020277691A1 (en)
CA (1) CA3140964A1 (en)
SG (1) SG11202112449SA (en)
WO (1) WO2020234450A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1971679B1 (en) 2006-01-13 2013-04-10 Osiris Therapeutics, Inc. Mesenchymal stem cells expressing tnf- receptor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
WO1992001070A1 (en) 1990-07-09 1992-01-23 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
DE69233013T2 (en) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer ADENOVIRUS MEDIATED GENTRANSFER INTO THE GASTROINTESTINAL TRACT
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
DE19939781C2 (en) 1999-08-21 2003-06-18 Schott Glas Skull crucible for melting or refining inorganic substances, especially glasses and glass ceramics
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
US10206951B2 (en) * 2011-06-03 2019-02-19 Mesoblast, Inc. Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells
CN103826646A (en) * 2011-06-03 2014-05-28 麦瑟布莱斯特公司 Method of treating the effects of stroke
JP6777840B2 (en) * 2015-12-25 2020-10-28 北海道公立大学法人 札幌医科大学 Drugs for the treatment of cerebral infarction

Also Published As

Publication number Publication date
US20220226386A1 (en) 2022-07-21
AU2020277691A1 (en) 2021-12-23
CN113853206A (en) 2021-12-28
WO2020234450A1 (en) 2020-11-26
CA3140964A1 (en) 2020-11-26
JP2022533781A (en) 2022-07-25
EP3972615A1 (en) 2022-03-30
KR20220011621A (en) 2022-01-28

Similar Documents

Publication Publication Date Title
CA189297S (en) Wheel
CA189308S (en) Wheel
CA189300S (en) Wheel
CA189319S (en) Wheel
CA189305S (en) Wheel
CA189318S (en) Wheel
CA189274S (en) Wheel
CA189296S (en) Wheel
CA189223S (en) Wheel
CA189287S (en) Wheel
ZA202202420B (en) Recovery over sidelink
CA189302S (en) Wheel
CA189294S (en) Wheel
CA189277S (en) Wheel
CA189278S (en) Wheel
CA189306S (en) Wheel
CA189273S (en) Wheel
GB2599286B (en) Grease recovery unit
SG11202112449SA (en) Functional recovery from cerebral infarction
GB2578655B (en) Metals recovery
CA189295S (en) Wheel
AP2016008988A0 (en) Gold Recovery from Carbon
AU2019902024A0 (en) Functional recovery from Cerebral Infarction
AU2019901756A0 (en) Functional recovery from Cerebral Infarction
CA189224S (en) Wheel